Shozo Ide
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 16
- Inflammatory Biomarkers in Disease Prognosis 8
- Cancer Immunotherapy and Biomarkers 5
- Peptidase Inhibition and Analysis 2
-
- Cancer, Lipids, and Metabolism 4
- MicroRNA in disease regulation 3
- Co-authors
- Yuji Toiyama (39 shared papers)Yoshinaga Okugawa (26 shared papers)Masato Kusunoki (44 shared papers)Toshimitsu Araki (23 shared papers)Hiromi Yasuda (24 shared papers)Koji Tanaka (20 shared papers)Hiroki Imaoka (14 shared papers)Hiroyuki Fujikawa (25 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)International Journal of Clinical Oncology (3 papers)Pediatric Surgery International (3 papers)Gastroenterology (3 papers)Surgery Today (3 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Shozo Ide
46 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Cancer Research 249
- Oncology 325
- Immunology 180
- Geriatrics and Gerontology 28
- Physiology 141
Countries citing papers authored by Shozo Ide
This map shows the geographic impact of Shozo Ide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shozo Ide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shozo Ide more than expected).
Fields of papers citing papers by Shozo Ide
This network shows the impact of papers produced by Shozo Ide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shozo Ide. The network helps show where Shozo Ide may publish in the future.
Co-authors
The 25 scholars most cited alongside Shozo Ide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 170 | |
| 2 | 2014 | 129 | |
| 3 | 2018 | 80 | |
| 4 | 2019 | 55 | |
| 5 | 2016 | 45 | |
| 6 | 2018 | 42 | |
| 7 | 2020 | 42 | |
| 8 | 2014 | 40 | |
| 9 | 2018 | 40 | |
| 10 | 2018 | 39 | |
| 11 | 2018 | 37 | |
| 12 | 2012 | 34 | |
| 13 | 2020 | 32 | |
| 14 | 2021 | 26 | |
| 15 | 2017 | 26 | |
| 16 | MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer. | 2015 | 23 |
| 17 | 2015 | 22 | |
| 18 | 2021 | 20 | |
| 19 | 2014 | 19 | |
| 20 | 2018 | 18 |
About Shozo Ide
Shozo Ide is a scholar working on Oncology, Cancer Research, Molecular Biology, Physiology and Surgery, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Nutrition and Health in Aging (5 papers), Cancer, Lipids, and Metabolism (4 papers), MicroRNA in disease regulation (3 papers), Lipid metabolism and disorders (3 papers), Circular RNAs in diseases (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (249 citations), Oncology (325 citations), Immunology (180 citations), Geriatrics and Gerontology (28 citations) and Physiology (141 citations). Shozo Ide has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Yuji Toiyama, Yoshinaga Okugawa, Masato Kusunoki, Toshimitsu Araki, Hiromi Yasuda, Koji Tanaka, Hiroki Imaoka, Hiroyuki Fujikawa, Tadanobu Shimura and Keiichi Uchida. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Clinical Oncology, Pediatric Surgery International, Gastroenterology and Surgery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.